| Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma A Shiras, ST Chettiar, V Shepal, G Rajendran, GR Prasad, P Shastry Stem Cells 25 (6), 1478-1489, 2007 | 216 | 2007 |
| The endothelial prolyl-4-hydroxylase domain 2/hypoxia-inducible factor 2 axis regulates pulmonary artery pressure in mice PP Kapitsinou, G Rajendran, L Astleford, M Michael, MP Schonfeld, ... Molecular and cellular biology 36 (10), 1584-1594, 2016 | 136 | 2016 |
| Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas G Rajendran, K Shanmuganandam, A Bendre, D Mujumdar, A Goel, ... Journal of neuro-oncology 104, 483-494, 2011 | 135 | 2011 |
| Metabolic flexibility in cancer: targeting the pyruvate dehydrogenase kinase: pyruvate dehydrogenase axis BL Woolbright, G Rajendran, RA Harris, JA Taylor III Molecular cancer therapeutics 18 (10), 1673-1681, 2019 | 121 | 2019 |
| EED and KDM6B coordinate the first mammalian cell lineage commitment to ensure embryo implantation B Saha, P Home, S Ray, M Larson, A Paul, G Rajendran, B Behr, S Paul Molecular and Cellular Biology 33 (14), 2691-2705, 2013 | 62 | 2013 |
| PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis A Paul, S Gunewardena, SR Stecklein, B Saha, N Parelkar, M Danley, ... Cell Death & Differentiation 21 (9), 1469-1481, 2014 | 52 | 2014 |
| Inhibition of protein kinase C signaling maintains rat embryonic stem cell pluripotency G Rajendran, D Dutta, J Hong, A Paul, B Saha, B Mahato, S Ray, P Home, ... Journal of Biological Chemistry 288 (34), 24351-24362, 2013 | 43 | 2013 |
| Inhibition of endothelial PHD2 suppresses post-ischemic kidney inflammation through hypoxia-inducible factor-1 G Rajendran, MP Schonfeld, R Tiwari, S Huang, R Torosyan, T Fields, ... Journal of the American Society of Nephrology 31 (3), 501-516, 2020 | 37 | 2020 |
| Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway R Torosyan, S Huang, PV Bommi, R Tiwari, SY An, M Schonfeld, ... Cell reports 36 (7), 2021 | 35 | 2021 |
| Regulation of mitochondrial function and cellular energy metabolism by protein kinase C-λ/ι: a novel mode of balancing pluripotency B Mahato, P Home, G Rajendran, A Paul, B Saha, A Ganguly, S Ray, ... Stem Cells 32 (11), 2880-2892, 2014 | 31 | 2014 |
| Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells EM Reddy, ST Chettiar, N Kaur, R Ganeshkumar, V Shepal, ... Cancer gene therapy 18 (3), 206-218, 2011 | 23 | 2011 |
| Role of MIF1/MIF2/CD74 interactions in bladder cancer BL Woolbright, G Rajendran, E Abbott, A Martin, S Amalraj, K Dennis, X Li, ... The Journal of pathology 259 (1), 46-55, 2023 | 10 | 2023 |
| Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer G Rajendran, JA Taylor III, BL Woolbright Cancer Drug Resistance 4 (1), 69, 2021 | 8 | 2021 |
| The endothelial PHD2/HIF-2 axis regulates pulmonary artery pressure in mice PP Kapitsinou, G Rajendran, L Astleford, MP Schonfeld, M Michael, ... Journal of Investigative Medicine 64 (4), 961-962, 2016 | 5 | 2016 |
| Pyruvate dehydrogenase kinase 4 deficiency increases tumorigenesis in a murine model of bladder cancer BL Woolbright, G Rajendran, E Abbott, A Martin, R Didde, K Dennis, ... Cancers 15 (6), 1654, 2023 | 1 | 2023 |
| Aging induces changes in cancer formation and microbial content in a murine model of bladder cancer BL Woolbright, H Xuan, I Ahmed, G Rajendran, E Abbott, K Dennis, ... GeroScience, 1-15, 2024 | | 2024 |
| Post-ischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis R Tiwari, R Sharma, G Rajendran, GS Borkowski, SY An, M Schonfeld, ... bioRxiv, 2023 | | 2023 |
| Intravenous vitamin C therapy for cisplatin ineligible bladder cancer patients (CI-MIBC): Early investigation into potential pharmacodynamic biomarkers BL Woolbright, G Rajendran, E Abbott, Z Zacharias, J Houtman, R Parikh, ... Cancer Research 83 (7_Supplement), 2119-2119, 2023 | | 2023 |
| MP14-18 MODELING BLADDER CANCER IN DOWN SYNDROME ANIMALS FOR DISCOVERY OF NOVEL THERAPEUTICS B Vo, E Abbott, C Vivian, X Moore, G Rajendran, S Weir, K Dennis, ... The Journal of Urology 209 (Supplement 4), e189, 2023 | | 2023 |
| Ts65Dn Down syndrome mice reveal a potential therapeutic vulnerability in a BBN bladder cancer model and subset of bladder cancer cell lines B Vo, E Abbott, CJ Vivian, X Moore, G Rajendran, K Dennis, ... Cancer Research 82 (12_Supplement), 3991-3991, 2022 | | 2022 |
